Data-to-Insight for R&D
Turning sparse, noisy, high-dimensional experimental data into actionable models - especially oligonucleotide, analytical, and multi-modal lab datasets.
Principal Solution Scientist
Scientific AI & ML · Multimodal Data · Computational Chemistry
I build practical ML systems that turn complex experimental and scientific data into working solutions - combining modelling, software engineering, and clear communication for R&D teams in life sciences, chemistry, and materials.
I'm a scientist and ML practitioner focused on measurable impact: faster process development, better use of messy experimental data, and systems that research teams can actually adopt. My path runs from an MChem at Strathclyde and polymer research at Huntsman (granted patent) through a Cambridge MPhil and PhD in computational chromatin biophysics, to industry delivery at Intellegens.
At Intellegens I led development of the Alchemite™ Oligonucleotide platform - from scientific strategy and implementation through product leadership to my current role as Principal Solution Scientist, designing multi-modal pipelines and bespoke solutions for enterprise R&D customers.
That work contributed to Intellegens being named a finalist for Life Science Company of the Year at the 2026 Cambridge Independent Science & Technology Awards. My PhD modelling underpins the Science Advances front-cover paper on linker histone H1 and chromatin organisation.
I use whatever approach fits the problem - coarse-grained simulation, classical ML, platform engineering, or careful data pipeline design - and I care about explaining results clearly to scientists, engineers, and commercial stakeholders.
Turning sparse, noisy, high-dimensional experimental data into actionable models - especially oligonucleotide, analytical, and multi-modal lab datasets.
Building extensions to Alchemite™, bespoke preprocessing, automation frameworks, and integrations across vendor platforms and custom infrastructure.
Multiscale chromatin modelling, phase behaviour, enhanced sampling (LAMMPS), and linking molecular simulation to experimental biology.
Customer trials and pilots, data-quality mitigation, live technical demos, and PoC-to-product collaboration with development and commercial teams.
Translating complex ML architectures into insights aligned with research objectives - for pharma, biotech, and materials audiences.
Conference talks, panels, posters, and technical writing on ML for oligonucleotides, process development, and scientific software.
Selected outputs - from peer-reviewed research, ChemRxiv preprints, and Intellegens product work. Full detail on my CV.
Research · Science Advances, 2026
Role: Computational modelling (PhD work); multiscale chromatin simulations supporting live-cell mechanistic framework.
Impact: Front-cover publication; bridges years of simulation development with experimental collaboration.
Read write-up · PaperProduct · Intellegens, 2024–2026
Role: Lead scientific/technical developer → innovation lead; predictive ML for synthesis, purification, and analytics.
Impact: Adoption by major industry partners; awards finalist; technical paper and recorded webinar.
Product · Technical paperPreprint · ChemRxiv, 2025
Role: Co-author (Intellegens); ML for SPOS process development, impurity analysis, and manufacturing optimisation.
Impact: Open-access preprint from the Intellegens–CPI oligonucleotide collaboration - summarises how machine learning can accelerate therapeutic oligo manufacturing.
ChemRxiv · DOII combine scientific framing, modelling, and engineering to deliver solutions that work in real R&D environments.
Clarify the experimental question, data constraints, and what success looks like for the team.
Prototype pipelines and models quickly - pilots, demos, and focused analyses before scaling.
Automated preprocessing, quality checks, and validation - especially where modalities and vendors differ.
Integrate into customer workflows, train users, and collaborate on productisation where impact is clear.
Tools and domains I work with regularly. Expand each category for detail.
Questions about my work or collaboration? Reach out via email or LinkedIn.